Therapeutics of diseases associated with hemoglobin (hbf/hbg) by inhibition of natural antisense transcript against hbf/hbg
CN110438125A
By inhibiting the natural antisense transcript of brain derived neurotrophic factor (BDNF) to treat BDNF related disease
EP2753317A1
TREATMENT OF DISEASES RELATED TO ALPHA SUBUNITS OF SODIUM CHANNELS, VOLTAGE-GATED (SCNxA) WITH SMALL MOLECULES
KR20140001225A
Treatment of nanog related diseases by inhibition of natural antisense transcript to nanog
KR20130138778A
Treatment of alpha-l-iduronidase (idua) related diseases by inhibition of natural antisense transcript to idua
EP2625274A2
Treatment of sialidase 4 (neu4) related diseases by inhibition of natural antisense transcript to neu4
CN103068982A
Treatment of discs large homolog (dlg) related diseases by inhibition of natural antisense transcript to dlg
TW201300115A
Treatment of sodium channel, voltage-gated, alpha subunit (scna) related diseases by inhibition of natural antisense transcript to scna
TW201916883A
Treatment of sodium channel, voltage-gated, alpha subunit (SCNA) related diseases by inhibition of natural antisense transcript to SCNA
CN107412251A
ATOH1 relevant diseases are treated by suppressing the natural antisense transcript of atonal homolog 1 (ATOH1)
TW201618793A
Treatment of par4 related diseases by inhibition of natural antisense transcript to par4
EP2556160A2
Treatment of fibroblast growth factor 21 (fgf21) related diseases by inhibition of natural antisense transcript to fgf21
EP2539452A2
Treatment of pyrroline-5-carboxylate reductase 1 (pycr1) related diseases by inhibition of natural antisense transcript to pycr1
EP2529015A2
Treatment of rnase h1 related diseases by inhibition of natural antisense transcript to rnase h1
KR20170115627A
Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt)
EP2521784A2
Treatment of interferon regulatory factor 8 (irf8) related diseases by inhibition of natural antisense transcript to irf8
EP2519632A2
Treatment of insulin receptor substrate 2 (irs2) related diseases by inhibition of natural antisense transcript to irs2 and transcription factor e3 (tfe3)
EP2515947A2
Treatment of uncoupling protein 2 (ucp2) related diseases by inhibition of natural antisense transcript to ucp2
CN102869776A
Treatment of hepatocyte growth factor (HGF) related diseases by inhibition of natural antisense transcript to HGF
KR20120091074A
Treatment of filaggrin (flg) related diseases by modulation of flg expression and activity
